The group's online pharmacy prescribes and supplies prescription-only medicines at a distance, mostly through its own pharmacist independent prescribers. Weight-loss medicines are the largest share, as injections and, since 2026, as licensed tablets too. Demand moves quickly, and prescribers can face hundreds of reviews in a shift, each built on a questionnaire, some uploaded evidence and an order history spread across several systems.
The rules have tightened. The GPhC's guidance for pharmacies providing services at a distance, updated in February 2025, says higher-risk medicines, including weight-loss medicines, must not be prescribed on a questionnaire alone. Weight, height or BMI must be independently verified, by video, in person, from clinical records or by contacting the patient's GP. The GPhC's April 2026 review found weight management in 77 inspection reports over two years, and 27% of 1,307 concerns were about prescribing practice, including missing BMI verification. Advertising is watched just as closely: the ASA and MHRA have acted against hundreds of ads for weight-loss prescription-only medicines.
Most people answer honestly. Some don't: a weight rounded up, someone else's photo, a second account at a different address, a re-order before the last pen could have been used, a child using a parent's details, or someone with an eating disorder who knows what to say. One prescriber looking at one order can't see most of this. And when an inspector or a concern asks what was checked for a particular supply, assembling the evidence takes days.